Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Qualcomm is drawing attention for holding up relatively well against semiconductor weakness and rebounding near technical support, with traders discussing bullish setups ahead of its next earnings report. Others remain cautious about reported performance-focused layoffs and the stocks history of uneven gains.

Hims & Hers is drawing attention over speculation that the administration may temporarily allow compounding pharmacies to sell certain restricted peptides while regulations are developed, a potential new growth opportunity for the company. Traders are largely hopeful but debate whether the policy will materialize and translate into lasting gains, amid frustration with the stocks persistent volatility and range-bound trading.

Disneys technical rebound and reported golden-cross signal are drawing attention, with traders watching whether shares can break through resistance near the recent high ahead of earnings. Bulls see momentum building, while others warn of repeated resistance and expect a pullback.

PANW is drawing attention amid a broad cybersecurity rally, with traders citing an Evercore channel survey pointing to firmer security budgets and headlines about AI-related vulnerabilities and PHP flaws as demand tailwinds. Many are bullish on the sectors momentum, while others question PANWs high valuation and flag earnings-related volatility.

Takeover speculation, including chatter about possible Lundbeck interest and a potential bidding war, has fueled attention, but no deal is confirmed and Xeris has said it is not for sale. Traders disagree on whether the rumor premium can last, while bullish holders also point to Recorlevs growth and XP-8121s planned Phase 3 as reasons to value the company independently.

Unconfirmed takeover chatterparticularly speculation about an unnamed West Coast technology buyer making an all-stock bid, with traders often guessing Metais dominating discussion. Many see a potential deal as a catalyst, while skeptics note that no offer is confirmed and point to upcoming earnings and PayPals turnaround as the more concrete tests.

Candels accepted SITC presentations on CAN-2409 in resistant NSCLC and CAN-3110 in recurrent glioblastoma have renewed pipeline interest, alongside anticipation of a planned prostate-cancer BLA submission. Bulls see the clinical updates and regulatory milestone as potential catalysts, while skeptics point to the share-price decline and concerns about dilution, timing, and CEO share sales.

SHIB is drawing attention amid choppy, largely range-bound trading, with traders watching technical levels and hoping for a broader memecoin rally or breakout. Bullish holders describe dips as accumulation opportunities, while skeptics point to the tokens sluggish performance, large supply and limited utility as reasons to doubt a sustained move.

Intuits fiscal 2027 outlook below expectations, despite a quarterly earnings beat, has fueled concern about slower growth and customer acquisition. Traders debate whether AI-powered tax and accounting alternatives threaten TurboTax and QuickBooks or whether the selloff overstates the risk to Intuits established, profitable software business.

BETRs sharp rebound is driving a short-squeeze discussion, with traders pointing to the announced share-repurchase program, a small float, and high reported short interest and borrowing costs as potential sources of buying pressure. Some see the rally as squeeze momentum, while others question whether it can continue without stronger volume or further operational progress.